SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004291
Filing Date
2018-05-08
Accepted
2018-05-08 16:02:11
Documents
68
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vvus-20180331x10q.htm 10-Q 1404386
2 EX-4.5 vvus-20180331ex45f560257.htm EX-4.5 103521
3 EX-31.1 vvus-20180331ex311e60d11.htm EX-31.1 19946
4 EX-31.2 vvus-20180331ex312e720a3.htm EX-31.2 19781
5 EX-32 vvus-20180331xex32.htm EX-32 16761
  Complete submission text file 0001558370-18-004291.txt   5055898

Data Files

Seq Description Document Type Size
6 EX-101.INS vvus-20180331.xml EX-101.INS 901573
7 EX-101.SCH vvus-20180331.xsd EX-101.SCH 41790
8 EX-101.CAL vvus-20180331_cal.xml EX-101.CAL 48134
9 EX-101.DEF vvus-20180331_def.xml EX-101.DEF 127028
10 EX-101.LAB vvus-20180331_lab.xml EX-101.LAB 350900
11 EX-101.PRE vvus-20180331_pre.xml EX-101.PRE 263537
Mailing Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008
Business Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008 6509345200
VIVUS INC (Filer) CIK: 0000881524 (see all company filings)

IRS No.: 943136179 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33389 | Film No.: 18814452
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1